Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing

Engineered mesenchymal stem cells (MSCs) have been investigated extensively for gene delivery and, more recently, for targeted small molecule delivery. While preclinical studies demonstrate the potential of MSCs for targeted delivery, clinical studies suggest that tumor homing of native MSCs may be...

Descripción completa

Detalles Bibliográficos
Autores principales: Prabha, Swayam, Merali, Carmen, Sehgal, Drishti, Nicolas, Emmanuelle, Bhaskar, Nitu, Flores, Magda, Bhatnagar, Shubhmita, Nethi, Susheel Kumar, Barrero, Carlos A., Merali, Salim, Panyam, Jayanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898454/
https://www.ncbi.nlm.nih.gov/pubmed/36747581
http://dx.doi.org/10.1016/j.mtbio.2023.100567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898454/
https://www.ncbi.nlm.nih.gov/pubmed/36747581
http://dx.doi.org/10.1016/j.mtbio.2023.100567

Ejemplares similares